A growing number of consumer products, marketed as a biological age test or biological age calculator, promise to tell a person their biological age, sometimes for the price of a saliva sample. The numbers, often presented as a comparison of biological age vs chronological age, are seductive, often surprising, and frequently misinterpreted. They are also a useful entry point into a real and increasingly mature field of measurement within longevity medicine. Biological age can be measured at the population level. The clinical question is how to read the numbers a particular individual receives, what those numbers mean, and what to do with them.

This article describes what biological age tests measure, where they are clinically useful, where they are oversold, and how a diagnostic-first preventive medicine approach uses them.

"Biological age" is a category of indices that estimate how a person's underlying biology is tracking relative to their chronological age. The category contains several distinct methods, each with different inputs and different track records.

EPIGENETIC CLOCKS

The most-cited biological age tests are epigenetic clocks, drawn from the field of epigenetics: algorithms that predict age from patterns of DNA methylation at specific sites in the genome. The original Horvath multi-tissue clock, published in 2013, used 353 methylation sites to predict chronological age across a wide range of human tissues with high accuracy [1]. The Hannum clock, published the same year, was derived from blood samples and is widely used in cardiovascular research [2].

These first-generation clocks were trained to predict chronological age. Their successors aimed at something more clinically useful. PhenoAge, developed by Levine and colleagues in 2018, combines methylation data with clinical biomarkers and was trained on mortality and disease outcomes [3]. GrimAge, developed by Lu and colleagues in 2019, was trained on time-to-death and outperforms earlier clocks at predicting mortality, cardiovascular disease, and cancer [4]. A more recent generation, including the principal-component-based PC-clocks, has substantially improved test-retest reliability. Earlier consumer products produced deviations of up to nine years between replicates of the same sample [5].

Epigenetic clocks comprise a family of tests with outputs that do not translate across clocks. A person whose GrimAge is two years above their chronological age has been given a different statement than one whose Horvath age is two years above theirs. The right question of a clock result is which clock, trained on what outcome.

A second category of biological age measures uses standard clinical markers instead of methylation data. Chronic low-grade inflammation, captured by inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP), is one of the most consistent predictors of all-cause mortality and cardiovascular events in middle and later life across large meta-analyses [6]. Insulin resistance and metabolic syndrome markers (fasting insulin, HbA1c, triglyceride-to-HDL ratio) track biological aging because they reflect the cumulative metabolic load on a person's tissues.

Composite scores built on routine bloods, of which PhenoAge is one, give a more clinically interpretable picture than a methylation number alone, partly because each component can be acted on independently.

FUNCTIONAL MEASURES

A third category sets aside laboratory tests entirely and measures physical performance directly. Cardiorespiratory fitness, measured as VO2 max, is one of the strongest single predictors of all-cause mortality across decades of follow-up; in a large cohort of more than 120,000 adults undergoing exercise testing, the mortality gradient remained steep even at the highest fitness levels, with no observed upper limit of benefit [7]. Grip strength predicts mortality and cardiovascular events in large international cohorts and outperforms blood pressure as a predictor in some analyses [8]. Gait speed in older adults predicts survival with an accuracy comparable to many laboratory composites [9].

Functional measures are inexpensive, repeatable, and modifiable. They deserve more weight in the biological age conversation than they typically receive.

The temptation, on receiving a biological age report, is to read one figure (usually the headline epigenetic age or its "delta" from chronological age) and to either celebrate or panic. Neither response is justified by what these tests can tell an individual.

The reasons are technical. First, test-retest reliability of first-generation clocks is poor enough that two samples from the same person on the same day can yield biological age estimates that differ by years; principal-component-based clocks have improved this, though the problem is not fully solved [5]. Second, biological age clocks measure correlations with outcomes at the population level; the predictive accuracy for any single individual is far lower than the headline numbers suggest. Third, different clocks measure different things (chronological age prediction, mortality risk, pace of biological change, tissue-specific aging), and a person can score "younger" on one and "older" on another from the same blood draw.

A single biological age number is, at best, the start of a conversation. A change in that number over time, paired with the clinical and functional context, is where the signal lives.

A point too often skipped in the consumer marketing: biological age clocks are statistical models, and their performance reflects the populations they were trained on. Most of the major first-generation clocks were developed on cohorts that were predominantly European-ancestry; performance in other ancestral groups is, on average, less precisely characterised and remains an active area of research.

Sex differences are also documented. Men show positive epigenetic age acceleration relative to women on multiple clocks, a pattern that has been linked to the well-known sex gap in lifespan [10]. For perimenopausal women specifically, biological age trajectories can show acceleration around the time of the menopausal transition (driven in part by ovarian aging) that does not appear in age-matched men. A flat "your biological age is X" output does not capture this kind of context, and a clinical interpretation should.

These tests retain clinical value. The interpretation, however, should treat any single number as a starting point for investigation.

A short, defensible framework for using these tests in practice contains four elements.

First, use them as a trend over time. A single biological age estimate is noisy; a series of estimates, alongside lifestyle and clinical changes, is informative. A six-month or twelve-month repeat with the same laboratory and the same clock is a more meaningful measurement than a single number in isolation.

Second, pair them with the clinical and functional substrate that explains the number. A high biological age coupled with elevated hs-CRP, insulin resistance, low VO2 max, and poor sleep tells a coherent story. A high biological age in an otherwise unremarkable workup tells a different one, and warrants caution before any intervention is built on it.

Third, treat the actionable components as the actionable components. Many of the inputs to clinical biological age scores (lipids, glucose, inflammation, fitness) are modifiable. The biological age headline is downstream of those inputs; clinical attention belongs upstream.

Fourth, be honest about what cannot be answered. Epigenetic clocks are research tools that have moved into consumer testing faster than the clinical evidence base has caught up. Their interpretation in any given individual deserves both clinical training and humility, and a place within a broader picture of health diagnostics.

The Nescens diagnostic model, delivered from a dedicated preventive medicine center, treats biological age estimation as one input among several. The starting point of any integrative medicine assessment is a multi-system picture: metabolic, cardiovascular, hormonal, cognitive, and musculoskeletal status, with sleep and lifestyle factors mapped alongside. Where they add interpretive value, epigenetic and composite biological age scores are run, repeated longitudinally, and interpreted in the context of the rest of the picture. The decisions that follow (about exercise, nutrition, sleep, hormonal management where appropriate, and medical surveillance) are guided by the underlying physiology.

The premise is the diagnostic-first one that underpins both the Essential Reset and the Female Health Program: interventions are valuable in proportion to the precision with which they are targeted, and any clinic offering longevity interventions without first measuring what they are intervening on is selling something less useful than it claims to be.

Biological age testing is one of the more interesting developments in clinical medicine over the last decade. It is also one of the more easily oversold. The most useful question a person can ask of these tests is which of their systems are aging fastest, and what can be done about it. Asked that way, the numbers become a diagnostic tool. Used well, they sharpen the picture that good preventive medicine is built on.